Nel ASA's Collins Aerospace Orders Total $20 Million, but the Profitability Question Remains Unanswered
Published on 10/12/2026 at 09:50 | Editorial boerse-global.de
Nel ASA has confirmed roughly $20 million in submarine-related business from Collins Aerospace, a figure that documents real customer demand but leaves the larger question of company-wide profitability untouched. The distinction matters: a booked order is evidence of business with a named client, not a verdict on earnings power.
What the orders actually cover
Nel Hydrogen US, the company's American subsidiary, received a purchase order from Collins Aerospace worth approximately $12 million about two weeks ago. The PEM electrolyzer stacks in question are destined for oxygen generation in life-support systems aboard US Navy submarines. Delivery is scheduled for 2027 and 2028.
Additional naval orders followed roughly a week ago, carrying a value of around $7 million according to company statements. Combined with the larger booking and smaller orders placed in September, the Collins business reached approximately $20 million. Those supplementary orders cover submarine programs in the United States, the United Kingdom and France.
The $20 million total should be read as an aggregate figure rather than as yet another standalone contract alongside the earlier announcements — several disclosures describe the same customer and the same field of application.
Should investors sell immediately? Or is it worth buying Nel ASA?
Booking and delivery are separate events
The announced delivery window extends well beyond the point of order. For investors, order intake and planned shipment are therefore distinct quantities: the booking records a customer's decision, while the delivery schedule describes how it is meant to be executed. Both belong in an assessment of the business, but they answer different questions.
This timing gap is central to how the upcoming quarterly report should be read. The orders will be captured in the third quarter of 2026, while the hardware itself will not ship until 2027 and 2028.
A skeptical view on profitability
Against that confirmed order intake stands a cautious analyst assessment published about two weeks ago. SB1 Markets lowered its price target on Nel from NOK 0.50 to NOK 0.30 and maintained its sell recommendation. According to media reports, analyst Andreas Skeisvoll Grimsmo justified the call by pointing to the absence of a clear path to profitability.
He also flagged possible additional capital needs. A capital raise in 2028 was mentioned as one possibility — not an announced corporate measure. That distinction prevents an analyst's expectation from being mistaken for a decided financing plan.
On the stock market, the shares showed a daily change of -1.3%. Confirmed customer orders thus sit opposite a negative trading signal, though no verified cause for the day's price movement follows from that pairing. Investors should resist equating order success with share price performance: the Collins contracts are a concrete business signal, and their informative value remains limited to the demand they describe. Anyone deriving a broader corporate trajectory from them is already taking an analytical step beyond the individual contract announcements.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
The next checkpoint
Nel announced a few days ago that it will publish its report for the third quarter of 2026 on October 15 at 07:00 CET. A virtual earnings presentation with a question-and-answer session will follow at 08:00 CET.
Until then, the more useful standard is a differentiated one: recognize confirmed orders as customer demand, account for the planned delivery horizon, and refrain from drawing automatic conclusions about the business as a whole. Whether the report also delivers arguments against the skeptical profitability view is the decisive valuation question.
Ad
Nel ASA Stock: New Analysis - 12 October
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
